相关实验视频
Updated: Jan 7, 2026

06:55
Ileectomy-induced Bile Overaccumulation in Mouse Intestine
Published on: August 21, 2017
9.9K
由梅萨拉引起的严重高胆固醇血症是性结肠炎的关键药物:一个病例报告
Takatoshi Anno1, Kazutoshi Murakami1, Shuhei Nakanishi2
1Department of Diabetic Medicine, Kurashiki Central Hospital, Japan.
Internal medicine (Tokyo, Japan)
|December 24, 2025
概括
梅萨拉是一种常见的性结肠炎治疗方法,可导致严重的高胆固醇血症. 类药物有效地控制了这种药物诱导的高胆固醇血症,突出了临床意识的必要性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
- 心脏病学 心脏病学
背景情况:
- 药物诱导的高胆固醇血症是必需的长期药物的已知不良影响.
- 梅萨拉是性结肠炎的主要治疗方法,尽管有潜在的副作用,但经常继续使用.
- 二次性高胆固醇血症需要对患者进行仔细的监测和管理.
研究的目的:
- 在性结肠炎患者中报告梅萨拉诱导的严重高胆固醇血症病例.
- 强调承认梅萨拉作为高胆固醇血症的潜在原因的重要性.
- 为了证明他类药物治疗治疗这种疾病的有效性.
主要方法:
- 使用了个案研究方法.
- 分析了一名患有性结肠炎的患者的临床数据,该患者在开始服用梅萨拉后经历了严重的高胆固醇血症.
- 用3 - 基-3 - 甲基氨酸辅酶A (HMG-CoA) 减少酶抑制剂进行治疗.
主要成果:
- 患者在服用梅萨拉后出现严重的高胆固醇血症.
- 用HMG-CoA减少酶抑制剂治疗导致脂质水平显著改善.
- 这一案例突出了以前未被充分认识到的梅萨拉的不良影响.
结论:
- 梅萨拉可以诱导性结肠炎患者的严重高胆固醇血症.
- HMG-CoA减少酶抑制剂 (他类药物) 在治疗美沙诱导的高胆固醇血症方面是有效的.
- 临床医生必须警这种潜在的副作用,以确保适当的患者护理.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
416
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
416
Chronic Bowel Disorders: Introduction
722
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
722
Inflammatory Bowel Disease I: Ulcerative Colitis
854
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
854
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
405
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
405
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
609
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
609
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
454
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
454

